Dopamine (DA) is a well-known neurotransmitter in the central nervous system (CNS). An increasing body of evidence, however, indicates that...
Aducanumab Shows Promise – Alzheimer’s A study recently published in the journal Nature indicates that aducanumab shows promise, in both...
Targeting Neuroinflammation – Alzheimer’s Disease Compelling new data published online in the journal CNS Drugs documents a substantial and significant...
TREM2 Microglia-Specific Gene – Alzheimer´s A study published in the May issue of Neuron indicates that the brain microglia and...
TLRs-Activated Microglia – Neurotoxic IL-17 A recent PLoS One study indicates that the cross-talk between the brain microglia and T...
Blocking IL-12 and IL-23 – Alzheimer’s Disease A recent study, published in Nature Medicine is perhaps the first one to...
Antibiotics -microbiota – gut-brain-axis A new Cell Reports study indicates that ‘inflammatory’ monocytes may represent the missing ‘pathogenic link’ between...
Clusterin Complement Proteins – Alzheimer’s A study recently published in the Journal of Alzheimer’s Disease gives hope in the search...
Perispinal Delivery Familiarity with the anatomy and physiology of the cerebrospinal venous system (CSVS) is necessary to understand the therapeutic...
Interleukin-33 – Cognitive Deficits Alzheimer’s A new study published in the Proceedings of the National Academy of Sciences USA (PNAS)...
The Einstein Aging Study – Stress – Risk of Dementia According to a recent report published in the journal Alzheimer...
Anticholinergic Drugs – Risk of Dementia A new report published in JAMA Internal Medicine (formerly, Archives of Internal Medicine) indicated...